PMV Pharmaceuticals, Inc. (PMVP)
1.27
-0.04
(-2.68%)
USD |
NASDAQ |
Oct 23, 16:00
1.275
0.00 (0.00%)
After-Hours: 20:00
PMV Pharmaceuticals EPS Diluted (Quarterly) : -0.3388 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.3388 |
| March 31, 2026 | -0.3382 |
| December 31, 2025 | -0.3385 |
| September 30, 2025 | -0.3974 |
| June 30, 2025 | -0.4078 |
| March 31, 2025 | -0.3356 |
| December 31, 2024 | -0.4429 |
| September 30, 2024 | -0.3728 |
| June 30, 2024 | -0.0236 |
| March 31, 2024 | -0.2968 |
| December 31, 2023 | -0.3063 |
| September 30, 2023 | -0.3393 |
| June 30, 2023 | -0.3806 |
| March 31, 2023 | -0.4179 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.4233 |
| September 30, 2022 | -0.3996 |
| June 30, 2022 | -0.3798 |
| March 31, 2022 | -0.4054 |
| December 31, 2021 | -0.4041 |
| September 30, 2021 | -0.3314 |
| June 30, 2021 | -0.2856 |
| March 31, 2021 | -0.2591 |
| December 31, 2020 | -0.2335 |
| September 30, 2020 | -0.1957 |
| June 30, 2020 | -0.178 |
| March 31, 2020 | -0.162 |
| December 31, 2019 | -0.1639 |
| September 30, 2019 | -0.138 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.09M |
| Total Expenses (Quarterly) | 18.09M |
| Enterprise Value | -11.32M |
| Earnings Yield | -111.3% |
| Normalized Earnings Yield | -111.25 |